Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

CDNA

CareDx (CDNA)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CDNA
DataOraFonteTitoloSimboloCompagnia
18/12/202413:05Business WireCareDx to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CDNACareDx Inc
11/12/202413:00Business WireCareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell TherapyNASDAQ:CDNACareDx Inc
11/12/202413:00PR Newswire (US)TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell TherapyNASDAQ:CDNACareDx Inc
06/12/202422:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDNACareDx Inc
04/12/202422:42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CDNACareDx Inc
18/11/202413:00Business WireGestion mondiale d’actifs CI annonce un nombre de fusions de fonds communs de placement et de FNB et une modification de la cote de risqueNASDAQ:CDNACareDx Inc
14/11/202423:13Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CDNACareDx Inc
12/11/202413:05Business WireCareDx to Participate in Upcoming Investor ConferencesNASDAQ:CDNACareDx Inc
04/11/202422:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CDNACareDx Inc
04/11/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDNACareDx Inc
04/11/202422:05Business WireCareDx Reports Third Quarter 2024 Results and Raises Revenue GuidanceNASDAQ:CDNACareDx Inc
23/10/202413:00Business WireCareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C TechnologyNASDAQ:CDNACareDx Inc
21/10/202413:00Business WireCareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics MeetingNASDAQ:CDNACareDx Inc
15/10/202412:00Business WireCareDx Reports Preliminary Financial Results for Third Quarter 2024NASDAQ:CDNACareDx Inc
11/10/202422:30Business WireCareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CDNACareDx Inc
09/10/202413:05Business WireCareDx Appoints Jing Huang Chief Data and AI OfficerNASDAQ:CDNACareDx Inc
08/10/202422:05Business WireCareDx to Host Investor Day on October 15, 2024NASDAQ:CDNACareDx Inc
08/10/202412:05Business WireCareDx Announces Closure of DOJ Investigation with No Finding of WrongdoingNASDAQ:CDNACareDx Inc
16/09/202422:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CDNACareDx Inc
14/09/202402:33Business WireCareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CDNACareDx Inc
13/09/202423:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CDNACareDx Inc
12/09/202413:01Business WireCareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial OfficerNASDAQ:CDNACareDx Inc
16/08/202420:10Business WireCareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap TestingNASDAQ:CDNACareDx Inc
31/07/202422:05Business WireCareDx Reports Second Quarter 2024 Results and Increases Revenue GuidanceNASDAQ:CDNACareDx Inc
16/07/202413:05Business WireCareDx to Report Second Quarter 2024 Financial ResultsNASDAQ:CDNACareDx Inc
03/06/202413:05Business WireLandmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable PatientsNASDAQ:CDNACareDx Inc
30/05/202413:05Business WireAI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant CongressNASDAQ:CDNACareDx Inc
29/05/202414:05Business WireCareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is IrrelevantNASDAQ:CDNACareDx Inc
24/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CDNACareDx Inc
16/05/202422:05Business WireLandmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer BiopsiesNASDAQ:CDNACareDx Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CDNA
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network